535 related articles for article (PubMed ID: 28451732)
1. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
Hasegawa T; Hayashida S; Kondo E; Takeda Y; Miyamoto H; Kawaoka Y; Ueda N; Iwata E; Nakahara H; Kobayashi M; Soutome S; Yamada SI; Tojyo I; Kojima Y; Umeda M; Fujita S; Kurita H; Shibuya Y; Kirita T; Komori T;
Osteoporos Int; 2019 Jan; 30(1):231-239. PubMed ID: 30406309
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
Shudo A; Kishimoto H; Takaoka K; Noguchi K
Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
[TBL] [Abstract][Full Text] [Related]
4. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Somay E
Osteoporos Int; 2023 Oct; 34(10):1811-1812. PubMed ID: 37418153
[No Abstract] [Full Text] [Related]
5. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
6. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
7. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
Cuozzo A; Iorio-Siciliano V; Vaia E; Mauriello L; Blasi A; Ramaglia L
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
[TBL] [Abstract][Full Text] [Related]
9. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy.
Hasegawa T; Ri S; Umeda M; Komatsubara H; Kobayashi M; Shigeta T; Yoshitomi I; Ikeda H; Shibuya Y; Asahina I; Komori T
J Craniomaxillofac Surg; 2013 Oct; 41(7):558-63. PubMed ID: 23332469
[TBL] [Abstract][Full Text] [Related]
10. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
11. Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?".
Hasegawa T
Osteoporos Int; 2023 Oct; 34(10):1809. PubMed ID: 37418154
[No Abstract] [Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
13. Tooth extraction in osteoporotic patients taking oral bisphosphonates.
Mozzati M; Arata V; Gallesio G
Osteoporos Int; 2013 May; 24(5):1707-12. PubMed ID: 23288026
[TBL] [Abstract][Full Text] [Related]
14. Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
Hasegawa T; Ueda N; Yamada SI; Kato S; Iwata E; Hayashida S; Kojima Y; Shinohara M; Tojo I; Nakahara H; Yamaguchi T; Kirita T; Kurita H; Shibuya Y; Soutome S; Akashi M;
Osteoporos Int; 2021 Nov; 32(11):2323-2333. PubMed ID: 33997909
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
16. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
[TBL] [Abstract][Full Text] [Related]
17. Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.
Ramaglia L; Guida A; Iorio-Siciliano V; Cuozzo A; Blasi A; Sculean A
Clin Oral Investig; 2018 Mar; 22(2):597-615. PubMed ID: 29332231
[TBL] [Abstract][Full Text] [Related]
18. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study.
Kwoen MJ; Park JH; Kim KS; Lee JR; Kim JW; Lee H; Lee HJ
J Periodontol; 2023 Jan; 94(1):98-107. PubMed ID: 35856336
[TBL] [Abstract][Full Text] [Related]
19. Oral bisphosphonate-induced osteonecrosis complications in patients undergoing tooth extraction: a systematic review and literature updates.
Dioguardi M; Di Cosola M; Copelli C; Cantore S; Quarta C; Nitsch G; Sovereto D; Spirito F; Caloro GA; Cazzolla AP; Aiuto R; Cascardi E; Greco Lucchina A; Lo Muzio L; Ballini A; Mastrangelo F
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):6359-6373. PubMed ID: 37458653
[TBL] [Abstract][Full Text] [Related]
20. The effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates.
Karaca Ç; Topaloğlu-Yasan G; Adiloğlu S; Usman E
J Korean Assoc Oral Maxillofac Surg; 2023 Apr; 49(2):68-74. PubMed ID: 37114444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
